January 10, 2011
FORWARD‐LOOKING STATEMENTS
FORWARD‐LOOKING STATEMENTS
Certain statements in this presentation may constitute “forward‐looking” statements that involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward‐looking statements. The Company disclaims any intention or obligation to update or revise any forward forward‐ looking statements, whether as a result of new information, future events or otherwise, other than as required by law.
2
ATRIUM OVERVIEW
ATRIUM OVERVIEW
•
•
Strong commitment to product development and improvements
Strong commitment to product development and improvements –
Innovation Science Committee with over 15 PhDs, MDs, nutritionists
& dieticians
•
Multi‐channel sales/distribution strategy:
Multi channel sales/distribution strategy:
– Healthcare practitioners
– Health food and specialized stores
– Direct‐to‐consumer
Direct to consumer
•
Seven GMP compliant manufacturing facilities
•
3
Extensive portfolio of best‐in‐class, science‐based and professionally endorsed dietary supplements primarily sold in North America and
Europe
g p $
Strategic and disciplined consolidator in $US80 billion+ worldwide industry Atrium s Mission
Atrium’s Mission
Grow. In Health.
G
I H lth
•
•
Atrium owns and develops unique individual business units that are dedicated to the promotion of health and well‐being
•
4
Atrium is committed to supporting optimal health through innovative science‐based products and services science based products and services
Atrium is proud to operate a vibrant family of premium brands
EXTENSIVE PRODUCT PORTFOLIO
EXTENSIVE PRODUCT PORTFOLIO
5
GEOGRAPHIC SALES MIX ‐ YEAR‐TO‐DATE
SALES MIX ‐
*
6
* Assuming an exchange rate of 1.35 euro/USD
FINANCIAL PERFORMANCE – 5 YEARS
FINANCIAL PERFORMANCE – 5 YEARS
2009
2005
CAGR
319.7
319 7
32.9
32 9
76.6%
76 6%
EBITDA
80.8
10.5
66.6%
Net Earnings
48.7
5.8
70.2%
$1.47
$0.20
64.7%
53.9
9.5
54.3%
(US$ Millions)
Revenues
EPS
Cash Flow before WC
7
CONVERGENCE – ATRIUM IS WELL POSTIONED
CONVERGENCE – ATRIUM IS WELL POSTIONED
Systemic movement from “disease care” to “preventive care” preventive care systems worldwide
8
Medicine
Nutrition
COMPLEMENTARY TO HEALTH & NUTRITION
COMPLEMENTARY TO HEALTH & NUTRITION
Preventive Health for
Current Pandemics
Diabetes
Reduced
Stress
Exercise
Dietary
Supplements
Diet
9
Obesity
Heart
ea t
Disease
Cancer
Consumers
• Growth in aging population
• T d t
Trends toward h lth li i d healthy living
• Self-care a d se educat o
Se ca e and self-education
• Alternative and/or complement to drugs • Soaring cost of drugs and healthcare 10
Medical Establishment Endorsement
• Growing support of medical community
• Part of the education of MDs
• More scientific evidence supporting industry • 80% of doctors/nurses use supplements
11
Governments
• H lh
Healthcare reforms worldwide f ld id
• Soaring cost of healthcare system and g y the role of preventive medicine
• Increased regulation worldwide
12
DIETARY SUPPLEMENT SALES – BY CHANNEL
DIETARY SUPPLEMENT SALES – BY CHANNEL
2009 U.S.
Supplement
Sales
$7.8
2004-2009
2008-2009
5.1%
10.1%
MLM
$4.5
2.9%
(3.1%)
Mail Order / TV / Radio
$1.5
3.5%
7.2%
Internet
$1.2
23.9%
32.6%
$7.1
5.2%
3.6%
Health Food and Specialized Stores p $9 9
$9.9
6 3%
6.3%
6 0%
6.0%
Healthcare Practitioners
$2.1
7.7%
8.2%
$26.9
5.7%
6.7%
(US$ Billions)
Mass Market
CAGR